Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scientist Home Future HealthSHFH +11.11%8 Equity-to-Asset is -0.16 as of Jun. 2026. GuruFocus rates SHFH with a GF Score™ of 8/100. The stock has 2 warning signs investors should review. Among 685 Healthcare Providers & Services companies, Scientist Home Future Health ranks worse than 92.41% on this metric.
The historical rank and industry rank for Scientist Home Future Health's Equity-to-Asset or its related term are showing as below:
SHFH'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.29 Med: 0.1 Max: 0.45
Current: -0.16
During the past 2 years, the highest Equity to Asset Ratio of Scientist Home Future Health was 0.45. The lowest was -0.29. And the median was 0.10.
SHFH's Equity-to-Asset is ranked worse than 92.41% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs SHFH: -0.16
Scientist Home Future Health (OTCPK:SHFH) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Scientist Home Future Health Equity-to-Asset Related Terms
Scientist Home Future Health Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scientist Home Future Health Equity-to-Asset Chart
SHFH vs BHIC, PETS, SCNX: Equity-to-Asset Comparison
For the Pharmaceutical Retailers subindustry, Scientist Home Future Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Scientist Home Future Health Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Scientist Home Future Health's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Scientist Home Future Health's Equity-to-Asset falls into.
Scientist Home Future Health Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Scientist Home Future Health's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scientist Home Future Health (SHFH) has a Equity-to-Asset of -0.16 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Scientist Home Future Health and its competitors. According to the industry distribution chart, Scientist Home Future Health ranks #633 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 92.4%.
Is Scientist Home Future Health's Equity-to-Asset too high?
Scientist Home Future Health's current Equity-to-Asset is -0.16. Based on the distribution chart, Scientist Home Future Health ranks #633 out of 685 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Scientist Home Future Health has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Scientist Home Future Health's Equity-to-Asset compare to BHIC and PETS?
According to the Healthcare Providers & Services industry distribution chart, Scientist Home Future Health ranks #633 out of 685 companies for Equity-to-Asset. This places Scientist Home Future Health in the lower half of its industry. The industry median Equity-to-Asset is 0.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Scientist Home Future Health and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scientist Home Future Health's current Equity-to-Asset is -0.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scientist Home Future Health stock overvalued right now?
Scientist Home Future Health (SHFH) has a current Equity-to-Asset of -0.16. The current Equity-to-Asset is -0.16. Scientist Home Future Health's overall GF Score™ is 8/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Scientist Home Future Health (SHFH), the current Equity-to-Asset is -0.16 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Scientist Home Future Health Ltd, through its subsidiaries, engages in the retail trading of health supplements and topical creams and provision of physical check-up services in Hong Kong. It focuses on developing sustainable rehabilitation solutions, particularly for degenerative diseases, ensuring that the products not only address current symptoms but also support future, long-term health and recovery. The company has two reportable segments based on business unit, retail trading and service business. The majority of revenue is derived from the Retail Trading segment, which derives revenue from customers by providing health supplements and topical creams. It has two reportable segments based on geographical location: Hong Kong and Non-Hong Kong; key revenue derives from Hong Kong.
8GF Score
Get the complete analysis for SHFH
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHFH has been successfully added to your 
